NASDAQ:LMAT LeMaitre Vascular (LMAT) Stock Price, News & Analysis $89.69 -1.83 (-2.00%) (As of 10/17/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends About LeMaitre Vascular Stock (NASDAQ:LMAT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get LeMaitre Vascular alerts:Sign Up Key Stats Today's Range$89.36▼$91.8250-Day Range$82.05▼$92.9352-Week Range$44.27▼$93.32Volume60,467 shsAverage Volume122,296 shsMarket Capitalization$2.01 billionP/E Ratio53.71Dividend Yield0.71%Price Target$94.67Consensus RatingModerate Buy Company OverviewLeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.Read More… Tim Sykes’ Urgent Trade Alert: “Make this move now” (Ad)WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…Click here to see a unique election-year trade LeMaitre Vascular Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks61st Percentile Overall ScoreLMAT MarketRank™: LeMaitre Vascular scored higher than 61% of companies evaluated by MarketBeat, and ranked 476th out of 1,012 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.4 / 5Analyst RatingModerate Buy Consensus RatingLeMaitre Vascular has received a consensus rating of Moderate Buy. The company's average rating score is 2.88, and is based on 5 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageLeMaitre Vascular has only been the subject of 4 research reports in the past 90 days.Read more about LeMaitre Vascular's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth12.97% Earnings GrowthEarnings for LeMaitre Vascular are expected to grow by 12.97% in the coming year, from $1.85 to $2.09 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of LeMaitre Vascular is 53.71, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 133.47.Price to Earnings Ratio vs. SectorThe P/E ratio of LeMaitre Vascular is 53.71, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 139.27.Price to Earnings Growth RatioLeMaitre Vascular has a PEG Ratio of 2.45. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioLeMaitre Vascular has a P/B Ratio of 6.70. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about LeMaitre Vascular's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted5.76% of the float of LeMaitre Vascular has been sold short.Short Interest Ratio / Days to CoverLeMaitre Vascular has a short interest ratio ("days to cover") of 9.2.Change versus previous monthShort interest in LeMaitre Vascular has recently increased by 15.69%, indicating that investor sentiment is decreasing significantly. Dividend3.3 / 5Dividend StrengthStrong Dividend YieldLeMaitre Vascular has a dividend yield of 0.71%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthLeMaitre Vascular has been increasing its dividend for 13 years.Dividend CoverageThe dividend payout ratio of LeMaitre Vascular is 42.38%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, LeMaitre Vascular will have a dividend payout ratio of 30.62% next year. This indicates that LeMaitre Vascular will be able to sustain or increase its dividend.Read more about LeMaitre Vascular's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted5.76% of the float of LeMaitre Vascular has been sold short.Short Interest Ratio / Days to CoverLeMaitre Vascular has a short interest ratio ("days to cover") of 9.2.Change versus previous monthShort interest in LeMaitre Vascular has recently increased by 15.69%, indicating that investor sentiment is decreasing significantly. News and Social Media2.6 / 5News Sentiment0.75 News SentimentLeMaitre Vascular has a news sentiment score of 0.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 10 news articles for LeMaitre Vascular this week, compared to 4 articles on an average week.Search InterestOnly 1 people have searched for LMAT on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows4 people have added LeMaitre Vascular to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership3.3 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, LeMaitre Vascular insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $266,272.00 in company stock.Percentage Held by Insiders10.79% of the stock of LeMaitre Vascular is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions84.64% of the stock of LeMaitre Vascular is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about LeMaitre Vascular's insider trading history. Receive LMAT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LeMaitre Vascular and its competitors with MarketBeat's FREE daily newsletter. Email Address LMAT Stock News HeadlinesCantor Fitzgerald Initiates Coverage of LeMaitre Vascular (LMAT) with Neutral RecommendationOctober 17 at 12:02 AM | msn.comLeMaitre Vascular (NASDAQ:LMAT) Earns Neutral Rating from Analysts at Cantor FitzgeraldOctober 16 at 4:29 AM | americanbankingnews.comThis man beat out 16,000 stock pickers to earn the #1 spotThere are very few people in this world who are considered “the best” in their field. There are guys like Michael Jordan who is considered the best basketball player of all time… Or Warren Buffet who is considered the best Investor of all time… But we’ve just met a man who might be the best stock picker of all time… Right now, as we speak, he is currently ranked the #1 stock picker in North America.October 17, 2024 | DTI (Ad)LeMaitre Will Announce Third Quarter 2024 Earnings Results October 31, 2024October 15 at 4:34 PM | globenewswire.comAnalyst Scoreboard: 4 Ratings For LeMaitre VascularOctober 15 at 12:24 PM | benzinga.comBrokerages Set LeMaitre Vascular, Inc. (NASDAQ:LMAT) Price Target at $94.40October 12, 2024 | americanbankingnews.comLeMaitre Vascular (NASDAQ:LMAT) Hits New 1-Year High - Still a Buy?October 9, 2024 | americanbankingnews.comLeMaitre Vascular Inc (LMAT) Q2 2024 Earnings Call Highlights: Strong Growth Across Key Metrics ...October 9, 2024 | finance.yahoo.comSee More Headlines LMAT Stock Analysis - Frequently Asked Questions How have LMAT shares performed this year? LeMaitre Vascular's stock was trading at $56.76 at the beginning of the year. Since then, LMAT shares have increased by 58.0% and is now trading at $89.69. View the best growth stocks for 2024 here. How were LeMaitre Vascular's earnings last quarter? LeMaitre Vascular, Inc. (NASDAQ:LMAT) issued its quarterly earnings results on Thursday, August, 1st. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.47 by $0.05. The company's revenue for the quarter was up 11.4% on a year-over-year basis. Does LeMaitre Vascular have any subsidiaries? LeMaitre Vascular subsidiaries include these companies: Artegraft, CardioCel, Tru-Incise (Eze-Sit) US, VascuCel, LeMaitre Cardial SAS, Syntel and Python, ProCol, and more. Who are LeMaitre Vascular's major shareholders? LeMaitre Vascular's top institutional investors include Annex Advisory Services LLC (0.13%), Kings Path Partners LLC (0.08%), Creative Planning (0.02%) and GAMMA Investing LLC. Insiders that own company stock include George W Lemaitre, David B Roberts, Joseph P Pellegrino Jr, Trent G Kamke, Bridget A Ross and John A Roush. View institutional ownership trends. How do I buy shares of LeMaitre Vascular? Shares of LMAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of LeMaitre Vascular own? Based on aggregate information from My MarketBeat watchlists, some other companies that LeMaitre Vascular investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and AUO (AUOTY). Company Calendar Last Earnings8/01/2024Ex-Dividend for 8/29 Dividend8/15/2024Dividend Payable8/29/2024Today10/17/2024Next Earnings (Confirmed)10/31/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:LMAT CUSIPN/A CIK1158895 Webwww.lemaitre.com Phone(781) 221-2266Fax781-425-5049Employees614Year Founded1983Price Target and Rating Average Stock Price Target$94.67 High Stock Price Target$105.00 Low Stock Price Target$75.00 Potential Upside/Downside+5.5%Consensus RatingModerate Buy Rating Score (0-4)2.88 Research Coverage8 Analysts Profitability EPS (Most Recent Fiscal Year)$1.51 Trailing P/E Ratio53.71 Forward P/E Ratio48.48 P/E Growth2.45Net Income$30.10 million Net Margins18.33% Pretax Margin24.05% Return on Equity12.41% Return on Assets10.78% Debt Debt-to-Equity RatioN/A Current Ratio8.36 Quick Ratio5.86 Sales & Book Value Annual Sales$205.62 million Price / Sales9.79 Cash Flow$1.72 per share Price / Cash Flow52.04 Book Value$13.38 per share Price / Book6.70Miscellaneous Outstanding Shares22,446,000Free Float20,045,000Market Cap$2.01 billion OptionableOptionable Beta0.88 Social Links 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report This page (NASDAQ:LMAT) was last updated on 10/17/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredRetire off just one stock ticker?ONE AI Stock is All You Need... There are over 6,000 stocks listed in the market right now. They will NOT m...Behind the Markets | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredAdd $2T of Potential Magic to Your PortfolioRevolutionizing a whole $2T entertainment and licensing industry might sound like the stuff of fairytales. But...Elf Labs | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMassive trading opportunity begins by October 21 October 21 could spark a mania among “next-generation” AI stocks. That’s the newest prediction from a Wall Str...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LeMaitre Vascular, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LeMaitre Vascular With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.